Gogce Crynen

the herbert wertheim uf scripps institute for biomedical innovation and technology

H指数:31

被引数:2,971

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Membrane-associated Rhes-Slc4a7 complex orchestrates tunneling nanotube formation and mutant Huntingtin spread

膜相关Rhes-Slc4a7复合物调控隧道纳米管形成及突变亨廷顿蛋白的传播

Science Advances

IF12.5

2026-03-200

In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor

NATURE BIOMEDICAL ENGINEERING

IF26.6

2024-12-050

PRE

Rhes, a striatal enriched protein, regulates post-translational small-ubiquitin-like-modifier (SUMO) modification of nuclear proteins and alters gene expression

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2024-04-080

OAAI

Ribosome Profiling and Mass Spectrometry Reveal Widespread Mitochondrial Translation Defects in a Striatal Cell Model of Huntington Disease

MOLECULAR & CELLULAR PROTEOMICS

IF5.5

2024-04-015

OAAI

In vivo affinity maturation of mouse B cells reprogrammed to express human antibodies

NATURE BIOMEDICAL ENGINEERING

IF26.6

2024-03-142

PRE

Low-Molecular Weight Small Molecules Can Potently Bind RNA and Affect Oncogenic Pathways in Cells

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2022-11-0211

Proximity interactome analysis of Lassa polymerase reveals eRF3a/GSPT1 as a druggable target for host-directed antivirals

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2022-07-189

OAAI

Functional interactomes of the Ebola virus polymerase identified by proximity proteomics in the context of viral replication

CELL REPORTS

IF6.9

2022-03-0111

OAAI

Rational Approach to Identify RNA Targets of Natural Products Enables Identification of Nocathiacin as an Inhibitor of an Oncogenic RNA

ACS CHEMICAL BIOLOGY

IF3.8

2022-01-195

Real-time digital polymerase chain reaction (PCR) as a novel technology improves limit of detection for rare allele assays

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2021-12-015

OAAI

Dyrk1a Mutations Cause Undergrowth of Cortical Pyramidal Neurons via Dysregulated Growth Factor Signaling

BIOLOGICAL PSYCHIATRY

IF9

2021-09-0119

OAAI

Reprogramming of Protein-Targeted Small-Molecule Medicines to RNA by Ribonuclease Recruitment

通过核糖核酸酶募集将蛋白质靶向的小分子药物重编程为RNA

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2021-08-1365

OAAI

APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains

MOLECULAR BRAIN

IF2.9

2021-07-0822

OAAI

A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2021-06-0125

OAAI

Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy

FRONTIERS IN AGING NEUROSCIENCE

IF4.5

2021-05-1710

OAAI

Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2

PLOS PATHOGENS

IF4.9

2021-04-0932

OAAI

Design of a small molecule that stimulates vascular endothelial growth factor A enabled by screening RNA fold-small molecule interactions

NATURE CHEMISTRY

IF20.2

2020-08-2443

OAAI

Comparative Analysis of Cleavage Specificities of Immobilized Porcine Pepsin and Nepenthesin II under Hydrogen/Deuterium Exchange Conditions

ANALYTICAL CHEMISTRY

IF6.7

2020-07-1315

PREAI

RasGRP1 is a causal factor in the development of L-DOPA-induced dyskinesia in Parkinson's disease

SCIENCE ADVANCES

IF12.5

2020-05-0120

OAAI

Unbiased Proteomic Approach Identifies Pathobiological Profiles in the Brains of Preclinical Models of Repetitive Mild Traumatic Brain Injury, Tauopathy, and Amyloidosis

无偏见的蛋白质组学方法确定重复性轻度创伤性脑损伤，tau蛋白病和淀粉样变性的临床前模型的大脑中的病理生物学特征

ASN NEURO

IF3.7

2020-04-0210

OAAI

Gogce Crynen

个人简介

教育背景

工作经历

荣誉奖项

研究方向